JIANGSU YAHONG MEDITECH CO., LTD. — Investor Relations & Filings
About JIANGSU YAHONG MEDITECH CO., LTD.
Jiangsu Yahong Meditech Co., Ltd., operating globally as Asieris Pharmaceuticals, is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative drugs for genitourinary tumors and related diseases. The company specializes in urology and women's health, addressing unmet medical needs through a pipeline of therapeutic and diagnostic solutions. Key assets include APL-1202, an oral MetAP2 inhibitor for bladder cancer, and APL-1702, a photodynamic therapy for cervical lesions. The firm also develops APL-1706, an imaging agent designed to improve the detection of bladder cancer. By integrating research, clinical development, and manufacturing capabilities, the company aims to provide comprehensive management strategies for patients worldwide.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 中信证券股份有限公司关于江苏亚虹医药科技股份有限公司首次公开发行股票并在科创板上市之保荐总结报告书 | 2026-04-29 | Chinese | |
| 江苏亚虹医药科技股份有限公司关于作废部分已授予但尚未归属的限制性股票的公告 | 2026-04-29 | Chinese | |
| 北京市嘉源律师事务所关于江苏亚虹医药科技股份有限公司2022年及2024年限制性股票激励计划归属条件成就及作废部分限制性股票的法律意见书 | 2026-04-29 | Chinese | |
| 江苏亚虹医药科技股份有限公司2026年第一季度报告 | 2026-04-29 | Chinese | |
| 中信证券股份有限公司关于江苏亚虹医药科技股份有限公司2025年度持续督导工作现场检查报告 | 2026-04-29 | Chinese | |
| 中信证券股份有限公司关于江苏亚虹医药科技股份有限公司2025年年度持续督导跟踪报告 | 2026-04-29 | Chinese |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
JIANGSU YAHONG MEDITECH CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58209/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58209 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58209 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58209 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58209}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for JIANGSU YAHONG MEDITECH CO., LTD. (id: 58209)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.